Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
| ▸ | GMNN | O75496 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | THPO | P40225 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | CETP | P11597 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | UBE2N | P61088 | 1/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL157112 | 0.78 | LMNA (0.47) | LMNACYP2D6SPHK1GMNNPOLB | |
| SCHEMBL4528803 | 0.77 | ALDH1A1 (0.39) | ALDH1A1LMNACYP2D6SPHK1GMNN | |
| SCHEMBL157318 | 0.75 | — | — | |
| SCHEMBL5408873 | 0.75 | — | — | |
| SCHEMBL28653199 | 0.75 | — | — | |
| SCHEMBL18923179 | 0.75 | — | — | |
| SCHEMBL28960499 | 0.74 | LMNA (0.46) | ALDH1A1LMNACYP2D6SPHK1GMNN | |
| SCHEMBL6683305 | 0.73 | — | — | |
| SCHEMBL6681302 | 0.73 | TSHR (0.39) | ALDH1A1LMNATSHR | |
| SCHEMBL31682128 | 0.70 | LMNA (0.46) | ALDH1A1LMNACYP2D6SPHK1GMNN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10000625-B2 | Flame retarding agent, flame-retardant aqueous resin composition and flame-retardant urethane resin composition containing said flame-retarding agent, and use therefor | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2018-06-19 | — | — | US | disclosed |
| EP-2868693-B1 | FLAME-RETARDANT AQUEOUS RESIN COMPOSITION COMPRISING A FLAME-RETARDANT AND A FLAME -RETARDANT SYNTHETIC LEATHER COMPRISING A FLAME RETARDANT URETHANE RESIN COMPOSITION CONTAINING A FLAME RETARDING AGENT | DAIHACHI CHEM IND (JP) | 2018-05-16 | — | — | EP | disclosed |
| US-20150197624-A1 | Flame Retarding Agent, Flame-Retardant Aqueous Resin Composition And Flame-Retardant Urethane Resin Composition Containing Said Flame-Retarding Agent, And Use Therefor | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2015-07-16 | — | — | US | disclosed |
| EP-2868693-A1 | FLAME RETARDING AGENT, FLAME-RETARDANT AQUEOUS RESIN COMPOSITION AND FLAME-RETARDANT URETHANE RESIN COMPOSITION CONTAINING SAID FLAME RETARDING AGENT, AND USE THEREFOR | Daihachi Chemical Industry Co., Ltd. (JP) | 2015-05-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10000625-B2 | Flame retarding agent, flame-retardant aqueous resin composition and flame-retardant urethane resin composition containing said flame-retarding agent, and use therefor | FFAR3, FFAR1, RFT1 | ALDH1A1 260/4885LMNA 2325/4885CYP2D6 2471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.